175 related articles for article (PubMed ID: 24838244)
1. Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.
Spyridaki K; Matsoukas MT; Cordomi A; Gkountelias K; Papadokostaki M; Mavromoustakos T; Logothetis DE; Margioris AN; Pardo L; Liapakis G
J Biol Chem; 2014 Jul; 289(27):18966-77. PubMed ID: 24838244
[TBL] [Abstract][Full Text] [Related]
2. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
[TBL] [Abstract][Full Text] [Related]
3. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
4. Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.
Bhattacharya S; Subramanian G; Hall S; Lin J; Laoui A; Vaidehi N
J Comput Aided Mol Des; 2010 Aug; 24(8):659-74. PubMed ID: 20512399
[TBL] [Abstract][Full Text] [Related]
5. Exploring the binding site crevice of a family B G protein-coupled receptor, the type 1 corticotropin releasing factor receptor.
Gkountelias K; Papadokostaki M; Javitch JA; Liapakis G
Mol Pharmacol; 2010 Oct; 78(4):785-93. PubMed ID: 20664003
[TBL] [Abstract][Full Text] [Related]
6. Selective antagonism of CRF1 receptor by a substituted pyrimidine.
Sakellaris S; Matsoukas MT; Karageorgos V; Poulaki S; Kuppast B; Margioris A; Venihaki M; Fahmy H; Liapakis G
Hormones (Athens); 2019 Jun; 18(2):215-221. PubMed ID: 30980254
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
8. Understanding Corticotropin Releasing Factor Receptor (CRFR) Activation Using Structural Models.
Cordomi A; Liapakis G; Matsoukas MT
Curr Mol Pharmacol; 2017; 10(4):325-333. PubMed ID: 28103783
[TBL] [Abstract][Full Text] [Related]
9. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
[TBL] [Abstract][Full Text] [Related]
10. Structure of class B GPCR corticotropin-releasing factor receptor 1.
Hollenstein K; Kean J; Bortolato A; Cheng RK; Doré AS; Jazayeri A; Cooke RM; Weir M; Marshall FH
Nature; 2013 Jul; 499(7459):438-43. PubMed ID: 23863939
[TBL] [Abstract][Full Text] [Related]
11. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
Liaw CW; Grigoriadis DE; Lorang MT; De Souza EB; Maki RA
Mol Endocrinol; 1997 Dec; 11(13):2048-53. PubMed ID: 9415408
[TBL] [Abstract][Full Text] [Related]
12. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
13. Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR.
Coin I; Katritch V; Sun T; Xiang Z; Siu FY; Beyermann M; Stevens RC; Wang L
Cell; 2013 Dec; 155(6):1258-69. PubMed ID: 24290358
[TBL] [Abstract][Full Text] [Related]
14. Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures.
Dore AS; Bortolato A; Hollenstein K; Cheng RKY; Read RJ; Marshall FH
Curr Mol Pharmacol; 2017; 10(4):334-344. PubMed ID: 28183242
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.
Seidel L; Zarzycka B; Zaidi SA; Katritch V; Coin I
Elife; 2017 Aug; 6():. PubMed ID: 28771403
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulators.
Kuppast B; Spyridaki K; Lynch C; Hu Y; Liapakis G; Davies GE; Fahmy H
Med Chem; 2014; 11(1):50-9. PubMed ID: 25059547
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic screening of class-B G protein-coupled receptors.
Devigny C; Perez-Balderas F; Hoogeland B; Cuboni S; Wachtel R; Mauch CP; Webb KJ; Deussing JM; Hausch F
J Am Chem Soc; 2011 Jun; 133(23):8927-33. PubMed ID: 21534574
[TBL] [Abstract][Full Text] [Related]
18. Molecular Basis for Hormone Recognition and Activation of Corticotropin-Releasing Factor Receptors.
Ma S; Shen Q; Zhao LH; Mao C; Zhou XE; Shen DD; de Waal PW; Bi P; Li C; Jiang Y; Wang MW; Sexton PM; Wootten D; Melcher K; Zhang Y; Xu HE
Mol Cell; 2020 Feb; 77(3):669-680.e4. PubMed ID: 32004470
[TBL] [Abstract][Full Text] [Related]
19. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
Assil IQ; Qi LJ; Arai M; Shomali M; Abou-Samra AB
Biochemistry; 2001 Feb; 40(5):1187-95. PubMed ID: 11170443
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.
Liapakis G; Karageorgos V; Andreadelis I; Holz GG; Dermitzaki E; Kordopati GG; Stylos EΚ; Spyridaki K; Poulaki S; Ntountaniotis D; Sakellaris S; Vanioti M; Kostagianni A; Marousis KD; Leonis G; Kokotos G; Venihaki M; Spyroulias GA; Tselios T; Margioris A; Tzakos AG; Mavromoustakos T
Amino Acids; 2020 Sep; 52(9):1337-1351. PubMed ID: 32996057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
